Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rodríguez-Fragoso

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 4, 1998
[Gene therapy]L Rodríguez-Fragoso
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|November 27, 1998
[Physiologic and physiopathologic role of hepatocyte growth factor]L Rodríguez-Fragoso
Pharmacology|December 1, 1995
Interferon-alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activatorL Rodríguez-Fragoso, M P González, P Muriel
Toxicology|April 11, 2001
Expression of urokinase-type plasminogen activator in an experimental model of hepatocarcinomaA Nieto-Rodríguez, R Hérnandez-Pando, D Kershenobich, et al.
Toxicology|October 8, 1999
Acetaldehyde increases the activity and gene expression of urokinase type plasminogen activator in a hepatic stellate cell lineL Rodríguez-Fragoso, R Alvarez, J A Reyes-Esparza, et al.
Proceedings of the Western Pharmacology Society|March 20, 2012
Pharmacological evaluation of the immunomodulatory FL-6 in induced chronic hepatitis in Wistar ratsU Osuna-Martinez, J A Reyes-Esparza, V l Petricevich, et al.
Journal of Applied Toxicology : JAT|May 1, 1997
Trimethylcolchicinic acid decreases liver fibrosis and cholestasis induced by prolonged biliary obstruction in the ratP Muriel, P U Ostoa-Saloma, J A Reyes-Esparsa, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 4, 1998
[Gene therapy]L Rodríguez-Fragoso
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|November 27, 1998
[Physiologic and physiopathologic role of hepatocyte growth factor]L Rodríguez-Fragoso
Pharmacology|December 1, 1995
Interferon-alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activatorL Rodríguez-Fragoso, M P González, P Muriel
Toxicology|April 11, 2001
Expression of urokinase-type plasminogen activator in an experimental model of hepatocarcinomaA Nieto-Rodríguez, R Hérnandez-Pando, D Kershenobich, et al.
Toxicology|October 8, 1999
Acetaldehyde increases the activity and gene expression of urokinase type plasminogen activator in a hepatic stellate cell lineL Rodríguez-Fragoso, R Alvarez, J A Reyes-Esparza, et al.
Proceedings of the Western Pharmacology Society|March 20, 2012
Pharmacological evaluation of the immunomodulatory FL-6 in induced chronic hepatitis in Wistar ratsU Osuna-Martinez, J A Reyes-Esparza, V l Petricevich, et al.
Journal of Applied Toxicology : JAT|May 1, 1997
Trimethylcolchicinic acid decreases liver fibrosis and cholestasis induced by prolonged biliary obstruction in the ratP Muriel, P U Ostoa-Saloma, J A Reyes-Esparsa, et al.
Pageof 1